1h Free Analyst Time
The Shrimp Disease Diagnostics Market size was estimated at USD 443.18 million in 2023, USD 478.10 million in 2024, and is expected to grow at a CAGR of 7.92% to reach USD 755.83 million by 2030. Speak directly to the analyst to clarify any post sales queries you may have.
Shrimp disease refers to various infectious and non-infectious conditions that affect the health, growth, and survival of shrimp in aquaculture systems. These diseases can be caused by various pathogens, such as bacteria, viruses, parasites, and fungi. The shrimp disease diagnostics technologies encompass various diagnostics tools such as morphological pathology (direct light microscopy, histopathology, electron microscopy), enhancement and bioassay methods, traditional microbiology, nucleic acid-based PCR assays, and serological methods to detect the prevalence of disease among shrimp population. The growing global demand for seafood products due to consumer preference for healthier protein sources and rising incidences of abiotic and biotic stresses and chronic diseases among the shrimp population has necessitated the deployment of shrimp disease diagnostics tools. However, the high cost of advanced diagnostic technologies may hinder the adoption of diagnostic tools among small-scale farms or developing countries. Furthermore, the lack of skilled personnel to perform complex diagnostic procedures and the absence of standardized testing protocols for shrimp disease prediction pose hurdles for the adoption of shrimp disease diagnostics strategies. To address these challenges and capitalize on existing opportunities, businesses operating within the shrimp disease diagnostics market should focus on innovation, research-driven product development, and collaboration with stakeholders across the industry. Furthermore, advancements in diagnostic technology and the utilization of nanotechnology for disease diagnosis can propel the growth and adoption of shrimp disease diagnostics.
Regional Insights
In the Americas, particularly Latin America and the Caribbean region, shrimp aquaculture is a major source of income for many coastal communities. The United States also has considerable coastal areas focused on aquaculture and shrimp production. In recent years, there has been an increased focus on implementing biosecurity measures to prevent the spread of diseases such as white spot syndrome virus (WSSV) and early mortality syndrome (EMS). There are some regional companies actively involved in research or product development related to shrimp disease diagnostics, and they offer molecular diagnostic services focused on early identification and management of pathogens affecting shrimps. Asia accounts for a large proportion of global shrimp production among China, India, Thailand, Vietnam, and Indonesia and requires proper diagnostics for this region's growing aquaculture sector. The company scenario in the Asian market is characterized by both international players providing a variety of diagnostic assays and instruments, as well as regional companies that focus on developing innovative solutions tailored to local needs. In Europe, countries, including Spain and France, emphasize biosecurity measures and strict monitoring protocols to prevent the introduction of diseases such as WSSV into their domestic farming operations. European countries contribute significantly to the development and production of advanced diagnostic tools for shrimp diseases. Some European institutions engage in research collaborations with aquaculture stakeholders from other regions to help improve diagnostics capabilities globally.FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Shrimp Disease Diagnostics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Shrimp Disease Diagnostics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.Key Company Profiles
The report delves into recent significant developments in the Shrimp Disease Diagnostics Market, highlighting leading vendors and their innovative profiles. These include 3 Little Fish Sdn Bhd, Amazing Biotech, Aquaintech Inc., Arachem (M) Sdn Bhd, Bioneer Corporation, Blue Aqua International Pte. Ltd., CD Genomics, China Guangzhou BioKey Healthy Technology Co. Ltd, DSM Austria GmbH, Forte Biotech, GeneReach Biotechnology Corp., GeneReach Biotechnology Corporation, Genics Pty. Ltd., Illumina, Inc., Innocreate Bioscience Co., Ltd., Lab-Ind Resource Sdn. Bhd., Laboratory Corporation of America Holdings, Mahesh Aqua Holdings (Pvt) Ltd., Mylab Discovery Solutions Pvt. Ltd., PT Riset Nusantara Genetika (Nusantics), Randox Laboratories Ltd., Reagen LLC, Ring Biotechnology Co Ltd., Speedy Assay Sdn. Bhd., SUREBIO, and Thermo Fisher Scientific Inc.Market Segmentation & Coverage
This research report categorizes the Shrimp Disease Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:- Kit
- Assay Based Kit
- Rapid Testing Kit
- Disease
- Early Mortality Syndrome
- Taura Syndrome Virus
- White Spot Syndrome Virus
- Yellow Head or Gill Associated Virus
- End User
- Aquaculture & Marine Laboratories
- Education & Research Institutes
- Fisheries
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
- Americas
The report offers valuable insights on the following aspects:
- Market Penetration: It presents comprehensive information on the market provided by key players.
- Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
- Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
- Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
- Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
- What is the market size and forecast of the Shrimp Disease Diagnostics Market?
- Which products, segments, applications, and areas should one consider investing in over the forecast period in the Shrimp Disease Diagnostics Market?
- What are the technology trends and regulatory frameworks in the Shrimp Disease Diagnostics Market?
- What is the market share of the leading vendors in the Shrimp Disease Diagnostics Market?
- Which modes and strategic moves are suitable for entering the Shrimp Disease Diagnostics Market?
Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report
Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.
With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.
This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.
Table of Contents
1. Preface
2. Research Methodology
4. Market Overview
5. Market Insights
6. Shrimp Disease Diagnostics Market, by Kit
7. Shrimp Disease Diagnostics Market, by Disease
8. Shrimp Disease Diagnostics Market, by End User
9. Americas Shrimp Disease Diagnostics Market
10. Asia-Pacific Shrimp Disease Diagnostics Market
11. Europe, Middle East & Africa Shrimp Disease Diagnostics Market
12. Competitive Landscape
13. Competitive Portfolio
14. Appendix
List of Figures
List of Tables
Companies Mentioned
- 3 Little Fish Sdn Bhd
- Amazing Biotech
- Aquaintech Inc.
- Arachem (M) Sdn Bhd
- Bioneer Corporation
- Blue Aqua International Pte. Ltd.
- CD Genomics
- China Guangzhou BioKey Healthy Technology Co. Ltd
- DSM Austria GmbH
- Forte Biotech
- GeneReach Biotechnology Corp.
- GeneReach Biotechnology Corporation
- Genics Pty. Ltd.
- Illumina, Inc.
- Innocreate Bioscience Co., Ltd.
- Lab-Ind Resource Sdn. Bhd.
- Laboratory Corporation of America Holdings
- Mahesh Aqua Holdings (Pvt) Ltd.
- Mylab Discovery Solutions Pvt. Ltd.
- PT Riset Nusantara Genetika (Nusantics)
- Randox Laboratories Ltd.
- Reagen LLC
- Ring Biotechnology Co Ltd.
- Speedy Assay Sdn. Bhd.
- SUREBIO
- Thermo Fisher Scientific Inc.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 197 |
| Published | March 2024 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 478.1 Million |
| Forecasted Market Value ( USD | $ 755.83 Million |
| Compound Annual Growth Rate | 7.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 26 |
